JP2022514084A5 - - Google Patents
Info
- Publication number
- JP2022514084A5 JP2022514084A5 JP2021535568A JP2021535568A JP2022514084A5 JP 2022514084 A5 JP2022514084 A5 JP 2022514084A5 JP 2021535568 A JP2021535568 A JP 2021535568A JP 2021535568 A JP2021535568 A JP 2021535568A JP 2022514084 A5 JP2022514084 A5 JP 2022514084A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- pharmaceutical composition
- composition according
- disorder
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862782938P | 2018-12-20 | 2018-12-20 | |
| US62/782,938 | 2018-12-20 | ||
| US201962834478P | 2019-04-16 | 2019-04-16 | |
| US62/834,478 | 2019-04-16 | ||
| PCT/US2019/067763 WO2020132401A1 (en) | 2018-12-20 | 2019-12-20 | Oral therapy using 6,8-bis-benzylthio-octanoic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022514084A JP2022514084A (ja) | 2022-02-09 |
| JP2022514084A5 true JP2022514084A5 (https=) | 2023-07-19 |
Family
ID=71101630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021535568A Pending JP2022514084A (ja) | 2018-12-20 | 2019-12-20 | ６，８－ビス－ベンジルチオ－オクタン酸を使用する経口療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220040133A1 (https=) |
| EP (1) | EP3897606A4 (https=) |
| JP (1) | JP2022514084A (https=) |
| KR (1) | KR20210105913A (https=) |
| CN (1) | CN113543779A (https=) |
| AU (1) | AU2019405976A1 (https=) |
| CA (1) | CA3121645A1 (https=) |
| IL (1) | IL283609A (https=) |
| MX (1) | MX2021007324A (https=) |
| TW (1) | TW202038930A (https=) |
| WO (1) | WO2020132401A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240033277A1 (en) * | 2020-12-03 | 2024-02-01 | New York Society for the Relief of the Ruptured and Crippled, maintaining the Hospital for Special | Methods for treating autoimmune diseases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8263653B2 (en) * | 2007-04-18 | 2012-09-11 | Cornerstone Pharmaceuticals, Inc. | Pharmaceutical formulations containing lipoic acid derivatives |
| WO2009110859A1 (en) * | 2008-03-04 | 2009-09-11 | Robert Shorr | Modulation of enzymatic structure, activity, and/or expression level |
| WO2011143590A1 (en) * | 2010-05-14 | 2011-11-17 | Cornerstone Pharmaceuticals, Inc. | Combination therapy compositions and methods using lipoic acid derivatives and an anti-proliferation agent |
| MA45865A (fr) * | 2016-08-07 | 2021-04-14 | Wistar Inst | Procédés de détection et de traitement d'une tumeur exprimant pt346 pdk1 |
| US20190160034A1 (en) * | 2017-03-20 | 2019-05-30 | Indiana University Research And Technology Corporation | Use of ape1/ref-1 inhibitors in combination therapies for treatment of cancer |
| WO2019055525A1 (en) * | 2017-09-12 | 2019-03-21 | Raj Selvaraj | FORMULATION OF SOLID NANOPARTICLES OF WATER-INSOLUBLE PHARMACEUTICAL SUBSTANCES WITH REDUCED OSTWALD CURING |
| US20210000778A1 (en) * | 2018-04-16 | 2021-01-07 | Rafael Pharmaceuticals, Inc. | Therapeutic methods and compositions for treating prostate cancer using 6,8-bis-benzylthio-octanoic acid |
| CN112469405A (zh) * | 2018-07-23 | 2021-03-09 | 拉斐尔制药股份有限公司 | 使用6,8-双(苄硫基)辛酸治疗胰腺癌的治疗方法和组合物 |
| US20220054445A1 (en) * | 2018-12-20 | 2022-02-24 | Rafael Pharmaceuticals, Inc. | Therapeutic methods and compositions for treating cancer using 6,8-bis-benzylthio-octanoic acid and an autophagy inhibitor |
| MX2021011250A (es) * | 2019-03-19 | 2022-02-11 | Rafael Pharmaceuticals Inc | Metodos y composiciones terapeuticas para tratar linfoma usando acido 6,8-bis-benciltio-octanoico. |
-
2019
- 2019-12-20 CA CA3121645A patent/CA3121645A1/en active Pending
- 2019-12-20 TW TW108147079A patent/TW202038930A/zh unknown
- 2019-12-20 CN CN201980084168.6A patent/CN113543779A/zh active Pending
- 2019-12-20 EP EP19898742.2A patent/EP3897606A4/en not_active Withdrawn
- 2019-12-20 JP JP2021535568A patent/JP2022514084A/ja active Pending
- 2019-12-20 KR KR1020217019808A patent/KR20210105913A/ko not_active Withdrawn
- 2019-12-20 WO PCT/US2019/067763 patent/WO2020132401A1/en not_active Ceased
- 2019-12-20 US US17/414,404 patent/US20220040133A1/en not_active Abandoned
- 2019-12-20 AU AU2019405976A patent/AU2019405976A1/en not_active Abandoned
- 2019-12-20 MX MX2021007324A patent/MX2021007324A/es unknown
-
2021
- 2021-06-01 IL IL283609A patent/IL283609A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3788047T3 (fi) | Fgft-estäjän kiinteitä muotoja ja menetelmiä niiden valmistamiseksi | |
| JP2019516733A5 (https=) | ||
| JP2006523216A5 (https=) | ||
| JP2023076465A5 (https=) | ||
| JP2019503365A5 (https=) | ||
| JP2021513536A5 (https=) | ||
| NZ602833A (en) | Oral formulations of cytidine analogs and methods of use thereof | |
| JP2014526503A5 (https=) | ||
| JP2015212268A5 (https=) | ||
| JP2019508440A5 (https=) | ||
| EA201492010A1 (ru) | Применение высокой дозы лахинимода для лечения рассеянного склероза | |
| JP2024516795A5 (https=) | ||
| JP2016502981A5 (https=) | ||
| MX2020012377A (es) | Uso de tabletas de desintegracion orales de riluzol para el tratamiento de enfermedades. | |
| MX2024007642A (es) | Uso de tabletas de desintegracion oral de riluzol para tratar enfermedades. | |
| JP2015507020A5 (https=) | ||
| JP2021529829A5 (https=) | ||
| JP2018522028A5 (https=) | ||
| JP2018516936A5 (https=) | ||
| JP2019510075A5 (https=) | ||
| JP2008514577A5 (https=) | ||
| JP2020536048A5 (https=) | ||
| JP2017516827A5 (https=) | ||
| JP2019534251A5 (https=) | ||
| JP2021505669A5 (https=) |